BG96513A - Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболяващ и болкоуспокояващ ефект и метод за тяхното получаване - Google Patents

Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболяващ и болкоуспокояващ ефект и метод за тяхното получаване

Info

Publication number
BG96513A
BG96513A BG096513A BG9651392A BG96513A BG 96513 A BG96513 A BG 96513A BG 096513 A BG096513 A BG 096513A BG 9651392 A BG9651392 A BG 9651392A BG 96513 A BG96513 A BG 96513A
Authority
BG
Bulgaria
Prior art keywords
obtainment
phenyl
substituted
local anesthetic
pain relief
Prior art date
Application number
BG096513A
Other languages
English (en)
Other versions
BG60912B1 (bg
Inventor
Anna-Lena Ask
Rune Sandberg
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of BG96513A publication Critical patent/BG96513A/bg
Publication of BG60912B1 publication Critical patent/BG60912B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Съединенията намират приложение като локални обезболяващи и болкоуспокояващи средства. Те имат обща формула изобретението се отнася и до методи за получаване на активните съединения, фармацевтичните препарати, които ги съдържат, и до приложението им. 8 претенции
BG96513A 1989-12-21 1992-06-19 Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболя- ващ и болкоуспокояващ ефект и метод за получаването им BG60912B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8904298A SE8904298D0 (sv) 1989-12-21 1989-12-21 New compounds
PCT/SE1990/000818 WO1991009845A1 (en) 1989-12-21 1990-12-17 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation

Publications (2)

Publication Number Publication Date
BG96513A true BG96513A (bg) 1993-12-24
BG60912B1 BG60912B1 (bg) 1996-06-28

Family

ID=20377821

Family Applications (1)

Application Number Title Priority Date Filing Date
BG96513A BG60912B1 (bg) 1989-12-21 1992-06-19 Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболя- ващ и болкоуспокояващ ефект и метод за получаването им

Country Status (40)

Country Link
US (2) US5227389A (bg)
EP (1) EP0506778B1 (bg)
JP (1) JP2656152B2 (bg)
KR (1) KR0179382B1 (bg)
CN (1) CN1037841C (bg)
AT (1) ATE138650T1 (bg)
AU (1) AU647068B2 (bg)
BG (1) BG60912B1 (bg)
BR (1) BR1100379A (bg)
CA (1) CA2069608C (bg)
CZ (1) CZ278035B6 (bg)
DE (1) DE69027221T2 (bg)
DK (1) DK0506778T3 (bg)
DZ (1) DZ1468A1 (bg)
EG (1) EG19361A (bg)
ES (1) ES2087280T3 (bg)
FI (1) FI100881B (bg)
HK (1) HK22997A (bg)
HR (1) HRP920591B1 (bg)
HU (1) HU213110B (bg)
IE (1) IE74855B1 (bg)
IL (1) IL96636A (bg)
IS (1) IS1664B (bg)
LT (1) LT4005B (bg)
LV (2) LV10949B (bg)
NO (1) NO178858C (bg)
NZ (1) NZ236293A (bg)
PL (1) PL163591B1 (bg)
PT (1) PT96303B (bg)
RO (1) RO112864B1 (bg)
RU (1) RU2039043C1 (bg)
SA (1) SA91110209B1 (bg)
SE (1) SE8904298D0 (bg)
SG (1) SG46413A1 (bg)
SI (1) SI9012346B (bg)
SK (1) SK658190A3 (bg)
UA (1) UA26403A (bg)
WO (1) WO1991009845A1 (bg)
YU (1) YU48086B (bg)
ZA (1) ZA909903B (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3916092B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 イミダゾリジノン誘導体とその酸付加塩及び老年性痴呆症の治療薬
SE9400447D0 (sv) * 1994-02-11 1994-02-11 Astra Ab New compounds
SE9404438D0 (sv) * 1994-12-21 1994-12-21 Astra Ab New process
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US20020102291A1 (en) * 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
WO2002083134A1 (en) * 2001-04-12 2002-10-24 Pharmacopeia, Inc. Aryl and biaryl piperidines used as mch antagonists
WO2004054974A2 (en) * 2002-12-13 2004-07-01 Smithkline Beecham Corporation Piperidine derivatives as ccr5 antagonists
CL2007002958A1 (es) * 2006-10-12 2008-05-09 Epix Delaware Inc Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
AU2008335135A1 (en) 2007-12-11 2009-06-18 Cytopathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
WO2020152212A1 (en) 2019-01-22 2020-07-30 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE96980C1 (bg)
US2486796A (en) * 1943-06-25 1949-11-01 Ciba Pharm Prod Inc Esters of 1-alkyl-4-hydroxyphenylpiperidyl-4-ketones
US3334106A (en) * 1964-10-20 1967-08-01 Aldrich Chem Co Inc N(aryl)n(hydrocarbyl)-omega-(4-phenyl-4-piperidinocarbonylheteroamine) alkanoamide
US3539580A (en) * 1967-06-26 1970-11-10 Janssen Pharm 4-aryl-4-aminoalkoxy-piperidines
CH502338A (de) * 1968-12-20 1971-01-31 Ciba Geigy Ag Verfahren zur Herstellung von neuen Piperidinderivaten
US3737538A (en) * 1968-12-30 1973-06-05 Ciba Geigy Corp Antitussive compositions and method with isonipecotic acid derivatives
FR2156470A2 (en) * 1971-10-21 1973-06-01 Synthelabo 1-(3,3-diphenyl-1-propyl)-4-aryl-piperidines - as analgesics spasmolytic and anti-tussive agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
US5100903A (en) * 1989-05-12 1992-03-31 Anaquest, Inc. N-aryl-n-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds

Also Published As

Publication number Publication date
UA26403A (uk) 1999-08-30
IS3659A7 (is) 1991-06-22
CZ278035B6 (en) 1993-07-14
JPH05502869A (ja) 1993-05-20
HRP920591A2 (en) 1997-08-31
ATE138650T1 (de) 1996-06-15
NZ236293A (en) 1992-10-28
IS1664B (is) 1997-07-04
FI100881B (fi) 1998-03-13
KR927003531A (ko) 1992-12-18
CN1037841C (zh) 1998-03-25
HU213110B (en) 1997-02-28
CA2069608C (en) 2001-07-10
SG46413A1 (en) 1998-02-20
PT96303A (pt) 1991-09-30
IE74855B1 (en) 1997-08-13
DZ1468A1 (fr) 2004-09-13
SA91110209B1 (ar) 2004-05-08
HRP920591B1 (en) 1998-12-31
DE69027221T2 (de) 1996-10-10
US5360805A (en) 1994-11-01
LV5766B4 (lv) 1997-06-20
IL96636A0 (en) 1991-09-16
DK0506778T3 (da) 1996-10-07
SE8904298D0 (sv) 1989-12-21
PT96303B (pt) 1998-07-31
RU2039043C1 (ru) 1995-07-09
BR1100379A (pt) 1999-12-07
EP0506778A1 (en) 1992-10-07
BG60912B1 (bg) 1996-06-28
LTIP1731A (en) 1995-07-25
YU48086B (sh) 1997-01-08
NO178858B (no) 1996-03-11
YU234690A (sh) 1993-10-20
LV5766A4 (lv) 1996-12-20
AU6978391A (en) 1991-07-24
NO922380D0 (no) 1992-06-17
SI9012346A (sl) 1998-08-31
ES2087280T3 (es) 1996-07-16
NO922380L (no) 1992-06-17
US5227389A (en) 1993-07-13
FI922806A (fi) 1992-06-17
RO112864B1 (ro) 1998-01-30
ZA909903B (en) 1991-08-28
CZ658190A3 (en) 1993-01-13
SK278283B6 (en) 1996-08-07
HUT64518A (en) 1994-01-28
KR0179382B1 (ko) 1999-03-20
CN1053605A (zh) 1991-08-07
WO1991009845A1 (en) 1991-07-11
CA2069608A1 (en) 1991-06-22
PL288409A1 (en) 1991-12-02
NO178858C (no) 1996-06-19
FI922806A0 (fi) 1992-06-17
IE904534A1 (en) 1991-07-03
AU647068B2 (en) 1994-03-17
SI9012346B (sl) 1999-08-31
EG19361A (en) 1994-12-30
EP0506778B1 (en) 1996-05-29
HK22997A (en) 1997-02-27
IL96636A (en) 1994-11-28
LV10949B (en) 1996-06-20
PL163591B1 (pl) 1994-04-29
LT4005B (en) 1996-07-25
LV10949A (lv) 1995-12-20
SK658190A3 (en) 1996-08-07
JP2656152B2 (ja) 1997-09-24
DE69027221D1 (de) 1996-07-04
HU9202044D0 (en) 1992-09-28

Similar Documents

Publication Publication Date Title
BG96513A (bg) Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболяващ и болкоуспокояващ ефект и метод за тяхното получаване
BR9709823B1 (pt) "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento".
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
ES2040208T3 (es) Pirazolinas insecticidas.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
NO870560L (no) Nytt farmasoeytisk preparat.
FI913100A0 (fi) Farmaceutiska preparat.
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
SE9400447D0 (sv) New compounds
DE69132575D1 (de) Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
IT7926854A0 (it) Derivato di creatinolo o-fosfato ad azione terapeutica, procedimento per la sua preparazione e relativ-e composizioni farmaceutiche.
OA08298A (fr) Nouvelles N-(aminométhyl-5 oxazolin-2 yl-2) N'-phénylurées, leur méthode de préparation ainsi que leur application thérapeutique.
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
BR9101973A (pt) Compostos quimicos,processo para a sua preparacao e composicoes farmaceutica e terapeutica
DK452788D0 (da) Smertestillende praeparat
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
FR2418226A1 (fr) Methoxy-2 alkylthio-5 benzamides et leur application en therapeutique
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene